Drug
Erenumab Aooe
Erenumab Aooe: highest development phase Phase 2, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Erenumab-Aooe NCT05142228 | Phase 2 | Trigeminal Neuropathy |
Latest
No recent events.
Follow Erenumab Aooe on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.